Zurich Cantonal Bank
VIR icon

Zurich Cantonal Bank’s Vir Biotechnology VIR Stock Holding History

Zurich Cantonal Bank’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$596K Buy
58,504
+15,166
+35% +$144K ﹤0.01% 1846
2026
Q1 		$388K Buy
43,338
+3,214
+8% +$25.6K ﹤0.01% 1957
2025
Q4 		$242K Sell
40,124
-406
-1% -$2.42K ﹤0.01% 2157
2025
Q3 		$231K Sell
40,530
-138
-0.3% -$706 ﹤0.01% 2124
2025
Q2 		$205K Sell
40,668
-323
-0.8% -$1.73K ﹤0.01% 2123
2025
Q1 		$266K Buy
40,991
+11,112
+37% +$98.8K ﹤0.01% 1950
2024
Q4 		$219K Buy
29,879
+4,648
+18% +$36.7K ﹤0.01% 2113
2024
Q3 		$189K Buy
25,231
+584
+2% +$5.07K ﹤0.01% 2136
2024
Q2 		$219K Buy
24,647
+3,215
+15% +$30.8K ﹤0.01% 1989
2024
Q1 		$217K Buy
21,432
+2,089
+11% +$21.3K ﹤0.01% 2010
2023
Q4 		$195K Hold
19,343
– – ﹤0.01% 2092
2023
Q3 		$181K Buy
19,343
+4,261
+28% +$60.8K ﹤0.01% 2034
2023
Q2 		$370K Buy
15,082
+3,499
+30% +$87.9K ﹤0.01% 1533
2023
Q1 		$270K Sell
11,583
-574
-5% -$14.7K ﹤0.01% 1689
2022
Q4 		$308K Buy
12,157
+3,028
+33% +$74.2K ﹤0.01% 1557
2022
Q3 		$176K Hold
9,129
– – ﹤0.01% 1830
2022
Q2 		$233K Sell
9,129
-55
-0.6% -$1.28K ﹤0.01% 1700
2022
Q1 		$236K Buy
9,184
+740
+9% +$21.9K ﹤0.01% 1788
2021
Q4 		$354K Buy
8,444
+1,780
+27% +$69.7K ﹤0.01% 1699
2021
Q3 		$290K Hold
6,664
– – ﹤0.01% 1665
2021
Q2 		$315K Buy
+6,664
New +$303K ﹤0.01% 1511

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Zurich Cantonal Bank's VIR Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Vir Biotechnology (VIR) stake by 35% in Q2 2026, buying an estimated $144K and bringing the position to 58,504 shares worth $596K. The position accounts for ﹤0.01% of the portfolio, ranked #1846.

Zurich Cantonal Bank first reported a position in VIR in Q2 2021 and has held it in 21 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Zurich Cantonal Bank held 58,504 shares of Vir Biotechnology worth $596K as of Q2 2026.
  • Zurich Cantonal Bank bought 15,166 Vir Biotechnology shares in Q2 2026, an estimated $144K.
  • Vir Biotechnology made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1846 holding.
  • Zurich Cantonal Bank first reported a position in Vir Biotechnology in Q2 2021 and has held it in 21 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.